{"id":"https://openalex.org/W2024830331","doi":"https://doi.org/10.1089/aid.2009.0217","title":"Analysis of RT Sequences of Subtype C HIV-Type 1 Isolates from Indian Patients at Failure of a First-Line Treatment According to Clinical and/or Immunological WHO Guidelines","display_name":"Analysis of RT Sequences of Subtype C HIV-Type 1 Isolates from Indian Patients at Failure of a First-Line Treatment According to Clinical and/or Immunological WHO Guidelines","alternate_titles":[],"publication_year":2010,"publication_date":"2010-03-01","ids":{"openalex":"https://openalex.org/W2024830331","doi":"https://doi.org/10.1089/aid.2009.0217","mag":"2024830331","pmid":"https://pubmed.ncbi.nlm.nih.gov/20334569"},"language":"en","primary_location":{"id":"doi:10.1089/aid.2009.0217","doi":"https://doi.org/10.1089/aid.2009.0217","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2009.0217","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2024830331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112777178","display_name":"Alaka K. Deshpande","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alaka Deshpande","raw_affiliation_strings":["ART Center and Department of Internal Medicine, Sir JJ Hospital, Byculla, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ART Center and Department of Internal Medicine, Sir JJ Hospital, Byculla, Mumbai, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088277487","display_name":"Anne C\u00e9cile Jeannot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne C\u00e9cile Jeannot","raw_affiliation_strings":["Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089505236","display_name":"Marie\u2010H\u00e9l\u00e8ne Schrive","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie H\u00e9l\u00e8ne Schrive","raw_affiliation_strings":["Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001041075","display_name":"Linda Wittkop","orcid":"https://orcid.org/0000-0003-2403-0960","observed_orcids":["https://orcid.org/0000-0003-2403-0960"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda Wittkop","raw_affiliation_strings":["INSERM U897, Universit\u00e9 de Bordeaux 2, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U897, Universit\u00e9 de Bordeaux 2, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090179389","display_name":"Patr\u00edcia Recordon-Pinson","orcid":"https://orcid.org/0000-0001-6002-0941","observed_orcids":["https://orcid.org/0000-0001-6002-0941"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia Pinson","raw_affiliation_strings":["Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043340550","display_name":"Herv\u00e9 J. Fleury","orcid":"https://orcid.org/0000-0002-5318-489X","observed_orcids":["https://orcid.org/0000-0002-5318-489X"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Herv\u00e9 J. Fleury","raw_affiliation_strings":["Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire EA 2968, Universit\u00e9 de Bordeaux 2, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5043340550"],"corresponding_institution_ids":["https://openalex.org/I15057530","https://openalex.org/I4405256745"],"apc_list":null,"apc_paid":null,"fwci":3.3375,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.91508479,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"26","issue":"3","first_page":"343","last_page":"350"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-subtype-c","display_name":"HIV-1 subtype C","score":0.9980000257492065},{"id":"https://openalex.org/keywords/reverse-transcriptase-mutations","display_name":"reverse transcriptase mutations","score":0.8109999895095825},{"id":"https://openalex.org/keywords/drug-resistance-mutations","display_name":"drug resistance mutations","score":0.8970000147819519},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.7900000214576721},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tenofovir-resistance","display_name":"tenofovir resistance","score":0.7829999923706055},{"id":"https://openalex.org/keywords/k65r","display_name":"K65R","score":0.8600000143051147},{"id":"https://openalex.org/keywords/nrti-resistance","display_name":"NRTI resistance","score":0.7110000252723694},{"id":"https://openalex.org/keywords/nnrti-resistance","display_name":"NNRTI resistance","score":0.9739999771118164},{"id":"https://openalex.org/keywords/indian-patients","display_name":"Indian patients","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6840367317199707},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.6801981329917908},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6139205694198608},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5186459422111511},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4405783414840698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43851208686828613},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1929543912410736},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17025226354599},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.12257733941078186}],"mesh":[{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007194","descriptor_name":"India","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024921","descriptor_name":"Drug Resistance, Multiple, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1089/aid.2009.0217","doi":"https://doi.org/10.1089/aid.2009.0217","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.2009.0217","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},{"id":"pmid:20334569","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20334569","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and human retroviruses","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00594701v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-00594701","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS Research and Human Retroviruses, 2010, 26 (3), pp.343-50. &#x27E8;10.1089/aid.2009.0217&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W22856828","https://openalex.org/W1503303110","https://openalex.org/W1974140637","https://openalex.org/W1985698850","https://openalex.org/W1986351652","https://openalex.org/W2002163141","https://openalex.org/W2023718095","https://openalex.org/W2084373400","https://openalex.org/W2088573476","https://openalex.org/W2124907347","https://openalex.org/W2162727299"],"related_works":["https://openalex.org/W2084373400","https://openalex.org/W2089150981","https://openalex.org/W2052818183","https://openalex.org/W2017039568","https://openalex.org/W2070137192","https://openalex.org/W7204254318","https://openalex.org/W2111121268","https://openalex.org/W2161771770","https://openalex.org/W2570048725","https://openalex.org/W1987223696"],"abstract_inverted_index":{"The":[0],"reverse":[1],"transcriptase":[2],"(RT)":[3],"sequences":[4],"of":[5,22,32,57,65,73,96,107],"HIV-1":[6,33],"subtype":[7,58],"C":[8],"isolates":[9,34],"from":[10,35],"Indian":[11],"patients":[12,37],"at":[13,68],"failure":[14],"(according":[15],"to":[16,30,49,87,102,112],"WHO":[17],"clinical":[18],"or":[19],"immunological":[20],"criteria)":[21],"a":[23,63],"first-line":[24],"treatment":[25],"including":[26,94,115],"d4T/AZT-3TC-NVP/EFV":[27],"were":[28,46,56],"compared":[29],"those":[31],"naive":[36],"and":[38,51,71,78,89,99],"analyzed":[39],"for":[40],"drug":[41],"resistance":[42,111],"mutations":[43],"(DRMs),":[44],"which":[45],"interpreted":[47],"according":[48],"ANRS":[50],"Stanford":[52],"algorithms.":[53],"All":[54],"viruses":[55],"C.":[59],"We":[60],"have":[61],"observed":[62],"decrease":[64],"the":[66,105],"polymorphism":[67],"positions":[69],"36":[70],"214":[72],"RT":[74],"while":[75],"D121Y,":[76],"V179I,":[77],"Q217E":[79],"could":[80,91],"be":[81,92],"new":[82],"DRMs.":[83],"Numerous":[84],"crucial":[85],"DRMs":[86,108],"NRTIs":[88,114],"NNRTIs":[90],"recorded":[93],"TAMs":[95],"pathway":[97],"1":[98],"K65R.":[100],"According":[101],"both":[103],"algorithms,":[104],"accumulation":[106],"may":[109],"induce":[110],"second-line":[113],"tenofovir.":[116]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2024830331","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
